Raynaud's phenomenon epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Raynaud's phenomenon}} | {{Raynaud's phenomenon}} | ||
'''Editors-In-Chief:''' Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D. | |||
' | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
== Overview == | == Overview == | ||
==Age== | |||
There is a familial component to primary Raynaud's, and presentation is typically before 30. | There is a familial component to primary Raynaud's, and presentation is typically before 30. | ||
==Gender== | |||
The phenomenon is more common in women than men, with the [[Framingham Heart Study|Framingham Study]] finding that 5.8% of men and 9.6% of women suffered from it. | The phenomenon is more common in women than men, with the [[Framingham Heart Study|Framingham Study]] finding that 5.8% of men and 9.6% of women suffered from it. | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Rheumatology]] | |||
[[Category:Syndromes]] | |||
[[Category:Autoimmune diseases]] | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Latest revision as of 18:55, 8 November 2012
|
Raynaud's phenomenon Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Raynaud's phenomenon epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Raynaud's phenomenon epidemiology and demographics |
|
Raynaud's phenomenon epidemiology and demographics in the news |
|
Risk calculators and risk factors for Raynaud's phenomenon epidemiology and demographics |
Editors-In-Chief: Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Age
There is a familial component to primary Raynaud's, and presentation is typically before 30.
Gender
The phenomenon is more common in women than men, with the Framingham Study finding that 5.8% of men and 9.6% of women suffered from it.